Long-acting intraocular Delivery strategies for biological therapy of age-related macular degeneration-Reference-Cited by-同舟云学术

Long-acting intraocular Delivery strategies for biological therapy of age-related macular degeneration

Published:2019-02 Issue: Volume:296 Page:140-149
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Iyer Shwetha,Radwan Ahmed E.,Hafezi-Moghadam Ali,Malyala Padma,Amiji Mansoor

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference53 articles.

1. No Title;Moore,1999

2. Ocular Delivery of Macromolecules;Manuscript,2015

3. Solubility Challenges in High Concentration Monoclonal Antibody Formulations: Relationship with Amino Acid Sequence and Intermolecular Interactions;Pindrus,2015

4. Ocular drug delivery;Gaudana;AAPS J.,2010

5. Ocular delivery of proteins and peptides: challenges and novel formulation approaches;Mandal;Adv. Drug Deliv. Rev.,2018

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biodegradable microspheres come into sight: A promising biomaterial for delivering drug to the posterior segment of the eyeball;Materials Today Bio;2024-08

2. Multifunctional Nanotherapeutics with Long-Acting Release against Macular Degeneration by Minimally Invasive Administration;ACS Nano;2024-07-17

3. Intravitreal therapeutic nanoparticles for age-related macular degeneration: Design principles, progress and opportunities;Advances in Colloid and Interface Science;2024-07

4. Long-Acting Strategies for Antibody Drugs: Structural Modification, Controlling Release, and Changing the Administration Route;European Journal of Drug Metabolism and Pharmacokinetics;2024-04-18

5. Compounding engineered mesenchymal stem cell-derived exosomes: A potential rescue strategy for retinal degeneration;Biomedicine & Pharmacotherapy;2024-04